Cargando…

Editorial: Profiling the tumour microenvironment to unveil biomarkers and develop novel therapeutics for cancer therapy

Detalles Bibliográficos
Autores principales:	Jaillon, Sebastien, Di Mitri, Diletta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074594/ https://www.ncbi.nlm.nih.gov/pubmed/37035333 http://dx.doi.org/10.3389/fmed.2023.1178532

Ejemplares similares

Editorial: Unveiling the Impact of Local or Systemic Therapeutic Strategies on the Tumor Microenvironment
por: Chen, Yun-Wang, et al.
Publicado: (2022)

Editorial: The role of novel hepatitis B biomarkers in solving therapeutic dilemmas
por: Lazarevic, Ivana, et al.
Publicado: (2023)

Editorial: Organ Fibrosis: Pathogenesis, Biomarkers and Therapeutic Targets
por: Mutsaers, Henricus A. M., et al.
Publicado: (2021)

NK Cells in Cancer: Mechanisms of Dysfunction and Therapeutic Potential
por: Portale, Federica, et al.
Publicado: (2023)

Editorial: Unveiling the tumor microenvironment by machine learning to develop new immunotherapeutic strategies
por: Zheng, Ping, et al.
Publicado: (2023)

Editorial: Therapeutic Opportunities and Innovative Biomarkers in Tumor Microenvironment
por: Xu, Kexin, et al.
Publicado: (2021)

Editorial: Tissue microenvironment in kidney diseases
por: Gui, Yuan, et al.
Publicado: (2023)

Editorial: Phenotypic and functional heterogeneity of neutrophils
por: Tamassia, Nicola, et al.
Publicado: (2023)

Editorial: Tumor adaptation to cellular stresses: mechanisms, biomarkers and therapeutic opportunities
por: Cortesi, Michela, et al.
Publicado: (2023)

Characterization of the Cellular Microenvironment and Novel Specific Biomarkers in Pterygia Using RNA Sequencing
por: Wolf, Julian, et al.
Publicado: (2022)

Editorial: Tumour microenvironment heterogeneity in hematological malignancies
por: Deaglio, Silvia, et al.
Publicado: (2023)

Editorial: Aldehyde dehydrogenase in clinical settings: Potential biomarker and therapeutic target in solid tumors
por: Aramini, Beatrice, et al.
Publicado: (2023)

Editorial: Biomarkers in CKD
por: Araujo, Magali, et al.
Publicado: (2017)

Editorial: Classical and Novel Biomarkers for Cardiovascular Disease
por: Perticone, Maria, et al.
Publicado: (2022)

Editorial: Lymphoid cells and tumor microenvironment: a functional crosstalk
por: Mimmi, Selena, et al.
Publicado: (2023)

Editorial: Novel diagnostic and therapeutic strategies for retinal diseases, volume II
por: Fang, Dong, et al.
Publicado: (2023)

Editorial: The Tumor Microenvironment: Recent Advances and Novel Therapeutic Approaches
por: Korkaya, Hasan, et al.
Publicado: (2020)

Editorial: Novel biomarkers for clinical and molecular stratification of organ involvement in rheumatic diseases
por: Sun, Xiaolin, et al.
Publicado: (2023)

Editorial: Inflammation and Biomarkers in Osteoarthritis
por: Mobasheri, Ali, et al.
Publicado: (2021)

Editorial: Biomarkers in Pulmonary Diseases
por: Mahboub, Bassam, et al.
Publicado: (2022)

Editorial: Advances in stem cell therapy: new applications and innovative therapeutic approaches
por: Marcuzzi, Annalisa, et al.
Publicado: (2023)

Editorial: Molecular biomarkers in hepatobiliary and pancreatic cancers: implications of non-coding RNAs and its therapeutic opportunities
por: Roy, Souvick, et al.
Publicado: (2023)

Editorial: The cross-talk between cancer cells and immune cells in the tumor microenvironment
por: Li, Tao, et al.
Publicado: (2023)

Editorial: The Microenvironment in Pancreatic Cancer and Therapeutic Strategies Targeting Microenvironment
por: Duan, Wanxing, et al.
Publicado: (2022)

Editorial: Updates in ocular therapeutics and surgery
por: Panos, Georgios D., et al.
Publicado: (2023)

Circular RNAs as Novel Diagnostic Biomarkers and Therapeutic Targets in Kidney Disease
por: Yu, Jianwen, et al.
Publicado: (2021)

Editorial: Novel and emerging therapies in heart failure
por: Giamouzis, Grigorios, et al.
Publicado: (2023)

Editorial: Omics biomarkers in inflammatory ocular diseases
por: Ttakeuchi, Masaru, et al.
Publicado: (2022)

Chemokines as Regulators of Neutrophils: Focus on Tumors, Therapeutic Targeting, and Immunotherapy
por: Bonecchi, Raffaella, et al.
Publicado: (2022)

Editorial: Understanding the crosstalk between immune cells and the tumor microenvironment in cancer and its implications for immunotherapy
por: Elemam, Noha Mousaad, et al.
Publicado: (2023)

Editorial: Thrombotic Microangiopathies, Diagnostic and Therapeutic Advances
por: Maitta, Robert W., et al.
Publicado: (2021)

Editorial: Therapeutic Advancements in Psoriasis and Psoriatic Arthritis
por: Panda, Saumya
Publicado: (2022)

Editorial: Next Therapeutic Targets in Ocular Diseases
por: Yanai, Ryoji, et al.
Publicado: (2022)

Novel Insight of CircRNAs in Cervical Cancer: Potential Biomarkers and Therapeutic Target
por: Wu, Maomao, et al.
Publicado: (2022)

Editorial: Developments in sickle cell disease therapy and potentials for gene therapy
por: Maitta, Robert W., et al.
Publicado: (2023)

Comprehensive Immune Profiling Unveils a Subset of Leiomyosarcoma with “Hot” Tumor Immune Microenvironment
por: Feng, Xiaolan, et al.
Publicado: (2023)

Editorial: Abdominal aortic aneurysms: advancements in diagnosis, biomarkers, drug therapeutics, surgical and endovascular treatment
por: Liu, Zhenjie
Publicado: (2023)

Editorial: Tumor microenvironment in cancer hallmarks and therapeutics
por: Luo, Na
Publicado: (2022)

Immunoprofiling in Neuroendocrine Neoplasms Unveil Immunosuppressive Microenvironment
por: Busse, Antonia, et al.
Publicado: (2020)

Editorial: Novel biomarkers for anticancer therapy
por: Wang, Ting, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m0pto5truvb4f3uu8rudevh5j9